10315-08-9 Usage
Chemical structure
The compound has a quaternary ammonium and bicyclic ring structure.
Synthetic compound
It is a synthetic compound, meaning it is not found naturally and is created through chemical synthesis.
Pharmaceutical applications
It has potential pharmaceutical applications as a muscarinic acetylcholine receptor antagonist.
Muscarinic acetylcholine receptor antagonist
This means that the compound can block the action of acetylcholine at muscarinic receptors, which are a type of receptor in the nervous system.
Neurological and psychiatric disorders
The compound may have applications in neurological and psychiatric disorders due to its potential ability to modulate cholinergic neurotransmission.
Cholinergic neurotransmission
This refers to the transmission of signals in the nervous system that involve the neurotransmitter acetylcholine.
Bicyclic structure
The compound has a bicyclic structure, which means it has two rings of atoms in its molecular structure.
Benzyl group
The compound has a benzyl group, which is a phenylmethyl group (C6H5CH2-) attached to the bicyclic ring structure.
Unique and interesting chemical
The compound's bicyclic structure and benzyl group make it a unique and interesting chemical for further study and development in pharmacology and medicinal chemistry.
Further study and development
The compound's properties and potential applications suggest that it may be worth further study and development in the fields of pharmacology and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 10315-08-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,1 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 10315-08:
(7*1)+(6*0)+(5*3)+(4*1)+(3*5)+(2*0)+(1*8)=49
49 % 10 = 9
So 10315-08-9 is a valid CAS Registry Number.
10315-08-9Relevant academic research and scientific papers
Process for the preparation of optically active 3-quinuclidinol
-
, (2008/06/13)
Optically active 3-quinuclidinol is obtained by the asymmetric hydrogenation of 3-quinuclidinone, its Lewis acid adducts or its tertiary or quaternary salts, for example, 1-(diphenylmethyl)-3-oxoquinuclidinium bromide. Rhodium/chiral diphosphine complexes with a metallocene structure are preferably used as catalysts. Optically active 3-quinuclidinol is a synthetic building block for pharmaceutical active substances (M1 receptor agonists).
Base Catalysed Rearrangements Involving Ylide Intermediates. Part 10. The Effects of Torsional Strain in the Transition State upon and Rearrangements
Ollis, W. David,Sutherland, Ian O.,Thebtaranonth, Yodhathai
, p. 1963 - 1968 (2007/10/02)
The and sigmatropic rearrangements of the bicyclic ammonium ylides (8), (11), and (14) are inhibited by the bicyclic framework which prevents correct orbital alignment for ?-bonding in the transition state for a concerted sigmatropic rea
